Inhibition of viruses
US7049303B2 · kind B2 · utility
2Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2002 |
| Grant date | May 23, 2006 |
| Priority date | — |
| Expiry date | Jan 29, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed is a pharmaceutical composition comprising a ribonucleoside analogue in accordance with general formula I or II as herein defined, in admixture with a physiologically acceptable excipient diluent or carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.